Roussel-Gaillard

2025

Posters

• Preliminary safety and efficacy 12 weeks results of PhagoDAIR-I, a Pilot Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus.
• Overview of Campylobacter spp. bone and joint infection in French reference centers
• Efficacy and safety of dalbavancin as suppressive therapy

2024

Publications

• Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme

2023

Communications orales

• Evaluation d’une technologie innovante de métagénomique ciblée 16S d’Oxford Nanopore Technologies pour améliorer le diagnostic des IOA complexes
• Improving the diagnosis of BJI : evaluation of 16S rRNA targetes metagenomics from Oxford Nanopore Technologies
• Exclusive medical treatment combining intraarticular injections of active bacteriophages as adjuvant therapy to antibiotics in patients with S. aureus complex PJI contraindicated for, or refusing, surgery

Cas cliniques

• Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales

Posters

• MULTICENTRE EVALUATION OF RAPID MOLECULAR SYNDROMIC APPROACH IN JOINT INFECTIONS USING A NEW DEDICATED PANEL : FILMARRAY® BIOFIRE® JOINT INFECTION

2022

Communications orales

• MULTICENTRE EVALUATION OF RAPID MOLECULAR SYNDROMIC APPROACH IN JOINT INFECTIONS USING A NEW DEDICATED PANEL: PRELIMINARY RESULTS

Publications

• Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages

2021

Posters

• Projet PHAGEinLYON – Traitement par phagothérapie des infections ostéo-articulaires à staphylocoques: caractérisation de dix-sept bactériophages anti-Staphylococcus
• Phage discovery: isolation and characterization of seventeen novel anti-Staphylococcus aureus bacteriophages